Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease

Conditions: Coronary Heart Disease Interventions: Drug: Ticagrelor; Drug: Clopidogrel; Drug: Aspirin Sponsors: Fu Wai Hospital, Beijing, China Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials